Scribd
Upload
19 views1 page

ICMR3

The Covid-19 test report for Imrana Ashraf Ali indicates a negative result for SARS-CoV-2, with the test conducted using the RTPCR method on a nasopharyngeal and oropharyngeal specimen. The sample was collected on November 30, 2021, and the result was reported on December 1, 2021. Important notes highlight that a single negative result does not exclude infection and that results should be correlated with clinical findings.

Uploaded by

chitrahddigital78
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
19 views1 page

ICMR3

The Covid-19 test report for Imrana Ashraf Ali indicates a negative result for SARS-CoV-2, with the test conducted using the RTPCR method on a nasopharyngeal and oropharyngeal specimen. The sample was collected on November 30, 2021, and the result was reported on December 1, 2021. Important notes highlight that a single negative result does not exclude infection and that results should be correlated with clinical findings.

Uploaded by

chitrahddigital78
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Covid-19 Test Report

Government Vellore Medical


College, Vellore

Individual Information
Covid-19 Test ID 647815186 Name: IMRANA ASHRAF ALI

Age: 31 Years Gender: Female

Contact Number: 9500284184 Country of Test: India

Adhaar Number: Not available Passport Number: N0110881

Specimen Information
ICMR ID: 588846761 SRF ID: 3359501253771

Result of SARS- Negative Test Type: RTPCR


CoV2:

Specimen Type: Nasopharyngeal & Oropharyngeal Report ID: GVMCVLR-21-73-1263

Date of Sample 30-11-2021 10:36:38 Date of Sample 30-11-2021 12:36:38


Collection: Received at Lab:

Date of Sample 01-12-2021 10:36:38 Date of Result 01-12-2021 16:59:14


Testing: Reported:

Note: The results relate only to the specimens tested and should be correlated with clinical findings.
Interpretation guidance:-
1. Testing of referred clinical specimens was considered on the basis of request / referral received from / through State Surveillance Officer (SSO) of concerned
State Integrated Disease Surveillance Programme (IDSP)/ any other health care facility affirming requirements of the case definition/s.
2. A single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection*
3. A positive test result is only tentative, and will be reconfirmed by retesting
4. Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimens may be
considered after a gap of 2 – 4 days after the collection of the first specimen for additional testing if required. *
5. A positive alternate pathogen does not necessarily rule out either, as little is yet known about the role of coinfections.
6. Please note that these results are not to be used for any thesis or presentations or for Publication in any Journal without the prior permission of the Director
General, ICMR
7. Report can be verified` at http://verify.icmr.org.in/

You might also like